Masahiro Kiuchi
YOU?
Author Swipe
View article: Increased expression of the <scp>PIEZO2</scp> mechanoreceptor in fibroblasts and endothelial cells within the lymphatic and vascular vessels of keloids
Increased expression of the <span>PIEZO2</span> mechanoreceptor in fibroblasts and endothelial cells within the lymphatic and vascular vessels of keloids Open
Keloids are scars that grow abnormally due to excessive extracellular matrix production by fibroblasts and increased angiogenesis. Chronic tension is implicated in their growth, but the exact pathology remains unclear. This study investiga…
View article: Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S3
View article: Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S3
View article: Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S2
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S2
View article: Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S1
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes Open
Table S1
View article: Amphiregulin-producing TH2 cells facilitate esophageal fibrosis of eosinophilic esophagitis
Amphiregulin-producing TH2 cells facilitate esophageal fibrosis of eosinophilic esophagitis Open
Amphiregulin, produced by TH2 cells, contributes to esophageal fibrosis in EoE and may be a therapeutic target.
View article: Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients Open
Purpose Auto-antibodies (auto-abs) to type I interferons (IFNs) have been identified in patients with life-threatening coronavirus disease 2019 (COVID-19), suggesting that the presence of auto-abs may be a risk factor for disease severity.…
View article: Hepatic ketone body regulation of renal gluconeogenesis
Hepatic ketone body regulation of renal gluconeogenesis Open
Our findings demonstrate that β-hydroxybutyrate mediates hepato-renal interaction to maintain homeostatic regulation of blood glucose and systemic acid-base balance through renal gluconeogenesis regulation.
View article: Single-cell RNA sequencing of submandibular gland reveals collagen type XV-positive fibroblasts as a disease-characterizing cell population of IgG4-related disease
Single-cell RNA sequencing of submandibular gland reveals collagen type XV-positive fibroblasts as a disease-characterizing cell population of IgG4-related disease Open
View article: The USP7-STAT3-granzyme-Par-1 axis regulates allergic inflammation by promoting differentiation of IL-5-producing Th2 cells
The USP7-STAT3-granzyme-Par-1 axis regulates allergic inflammation by promoting differentiation of IL-5-producing Th2 cells Open
Uncontrolled type 2 immunity by type 2 helper T (Th2) cells causes intractable allergic diseases; however, whether the interaction of CD4 + T cells shapes the pathophysiology of allergic diseases remains unclear. We identified a subset of …
View article: Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S1
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S3
View article: Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Tumor-specific CD8+ T cells play a pivotal role in antitumor immunity and are a key target of immunotherapeutic approaches. Intratumoral CD8+ T cells are heterogeneous; Tcf1+ stemlike CD8+ T cell…
View article: Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S1
View article: Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S2
View article: Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S3
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S2
View article: Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S1
View article: Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Tumor-specific CD8+ T cells play a pivotal role in antitumor immunity and are a key target of immunotherapeutic approaches. Intratumoral CD8+ T cells are heterogeneous; Tcf1+ stemlike CD8+ T cell…
View article: Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Data from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Tumor-specific CD8+ T cells play a pivotal role in antitumor immunity and are a key target of immunotherapeutic approaches. Intratumoral CD8+ T cells are heterogeneous; Tcf1+ stemlike CD8+ T cell…
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11
View article: Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S3
View article: Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes Open
Table S2